The clinical diagnostic tests performed by laboratories can be broadly classified into four major categories, namely, clinical chemistry, medical microbiology & cytology, human and tumour genetics and other esoteric tests. Ranging from routine blood and urine tests to high-end genetic analysis including fluorescence in situ hybridization (FISH), molecular expression testing, etc., clinical laboratories offer numerous tests that help detect disease progression and abnormalities. The three major types of service providers in this market include hospital-based laboratories, clinic-based laboratories and stand-alone laboratories. The global market for clinical laboratory services is expected to record a CAGR of 5.8% during the forecast period of 2013 to 2019, to grow from a USD 162.71 billion market in 2012 to a USD 241.37 billion market in 2019.
With the increasing incidence rates of debilitating conditions such as cancer, diabetes and infectious diseases, the number of patients that will opt for such tests will continue to increase in the future and thereby increase the demand for these services. Moreover, the percentage of aged population in the U.S. is expected to grow to an estimated 20% by 2030. Such a large population of elderly people in the U.S. alone will lead to high testing volumes for clinical laboratories. Diagnostics manufacturers such as Roche Holdings, Genomic Health, Abbott Diagnostics, Qiagen, etc. are focusing their efforts towards developing products and systems that would enable highly accurate analysis of patient samples and also enable processing of thousands of samples at a time. This will help clinical laboratories to cope with the rising demand and in turn ensure revenue generation.
The clinical laboratory services market in Asia-Pacific is expected to show tremendous growth during the period 2013 to 2019, owing to the large population of the region with high unmet medical needs. The healthcare reimbursement scenario in this region being highly unorganized, may slightly hamper the growth of this market. However, lack of stringent regulatory framework will offset this and ensure growth during the forecast period. North America, which leads the market in terms of revenue generation, is expected to continue to do so during the forecast period due to the sophisticated healthcare infrastructure, favorable reimbursement scenario and the increasing incidence rates of diseases.
The dominance of hospital-based laboratories will continue throughout the forecast period due to the huge difference in testing volumes of these laboratories as compared to the other two. However, stand-alone laboratories are gaining increasing importance in the wake of quicker sample processing and ease of access for patients.
The market is highly oligopolistic in nature with a few major players accounting for more than 50% of the market. Some of the market leaders in this space include Laboratory Corporation of America Holdings, Quest Diagnostics, Inc., Sonic Healthcare, Healthscope, Genoptix Medical Laboratory, Labco S.A., Charles River Laboratories, Bio-Reference Laboratories, Spectra Laboratories, and Abbott Laboratories.
With the high incidence of debilitating health conditions such as diabetes, cancer, and other chronic ailments, the demand for clinical laboratory services has significantly increased among patients. The clinical diagnostics, or in-vitro diagnostics market comprises assays, instruments, and services that help in the diagnosis and treatment of diseases. The global healthcare community foresees great prospects for the clinical laboratory services market, since it offers personalized medicine and administers accurate therapies at the right time to the right patient with minimal risk of errors.
The report on the global clinical laboratory services market provides an all-encompassing overview of the prevailing trends and dynamics of the market. It has adopted an analytical approach to study the growth trajectory that the market exhibits. As a part of the study, the report segments the global clinical laboratory services market into four major categories based on the clinical diagnostics tests performed in laboratories. These include human and tumor genetics, medical microbiology and cytology, clinical chemistry, and other esoteric tests.
Clinical laboratory services include several tests that help detect abnormalities and disease progression, ranging from regular blood and urine tests to sophisticated genetic analyses such as molecular expressing testing, fluorescence in situ hybridization, and others. Stand-alone laboratories, clinic-based laboratories, and hospital-based laboratories are the key service providers in the market.
Overview of the Clinical Laboratory Services Market
The global clinical laboratory services market is anticipated to exhibit a 5.8% CAGR between 2013 and 2019. The market is expected to grow from US$162.71 billion in 2012 to an estimated valuation of US$241.37 billion in 2019.
Increasing prevalence of chronic ailments, especially among the geriatric populace, is expected to boost the demand for clinical laboratory services. In the U.S., the geriatric demographic is likely to expand by 20% by 2030. Such an increase in the population of aging people in the U.S. alone will result in higher volumes of clinical laboratory testing.
To offer more accurate diagnosis, prominent market players such as Abbott Diagnostics, Roche Holdings, Roche Holdings, Genomic Health, and others are investing on the development of systems and products that will help obtain highly accurate analysis of patient samples and enable processing thousands of samples in time. Such research and development activities will help the clinical laboratory services market cope with the rising demand.
Over the forecast period between 2013 and 2019, the clinical services laboratory market in Asia Pacific is expected to register incredible growth. Asia Pacific boasts a large population with high prevalence of unmet medical needs. This provides a tremendous growth opportunity for the clinical laboratory services market. In terms of revenue generation, North America leads the market at present and is expected to continue its dominance over the forecast period.
Companies mentioned in the research report
The global clinical laboratory services market is oligopolistic in nature, with only a handful of major players collectively accounting for over 50% of the market. Some of the leading players operating in the market are Charles River Laboratories, Laboratory Corporation of America Holdings, Genoptix Medical Laboratory, Bio-Reference Laboratories, Quest Diagnostics, Inc., Sonic Healthcare, Spectra Laboratories, Healthscope, Labco S.A., and Abbott Laboratories.
Clinical Laboratory Services Market, by Test Type
- Clinical Chemistry
- Medical Microbiology & Cytology
- Human & Tumor Genetics
- Other Esoteric Tests
Clinical Laboratory Services Market, by Service Provider
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments